A phase III study to evaluate the long-term safety and efficacy of fasinumab in patients with pain due to osteoarthritis of the knee or hip.

DiMartino SJ, Mei J, Schnitzer TJ, Gao H, Eng S, Winslow C, Ho T, Turner KC, Hassan HE, Patel Y, Davis JD, Trinh N, Manley A, Manvelian G, Fetell M, Braunstein N, Geba GP, Dakin P.

Open source

DOI
10.1016/j.ocarto.2024.100533
Published
2024-10-22
Container
Osteoarthr Cartil Open
Publisher
Not recorded
Open access
yes

Credibility signals

uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.ocarto.2024.100533,
  title = {A phase III study to evaluate the long-term safety and efficacy of fasinumab in patients with pain due to osteoarthritis of the knee or hip.},
  author = {DiMartino SJ and  Mei J and  Schnitzer TJ and  Gao H and  Eng S and  Winslow C and  Ho T and  Turner KC and  Hassan HE and  Patel Y and  Davis JD and  Trinh N and  Manley A and  Manvelian G and  Fetell M and  Braunstein N and  Geba GP and  Dakin P.},
  year = {2024},
  journal = {Osteoarthr Cartil Open},
  doi = {10.1016/j.ocarto.2024.100533},
  url = {https://doi.org/10.1016/j.ocarto.2024.100533}
}

RIS

TY  - JOUR
TI  - A phase III study to evaluate the long-term safety and efficacy of fasinumab in patients with pain due to osteoarthritis of the knee or hip.
AU  - DiMartino SJ
AU  -  Mei J
AU  -  Schnitzer TJ
AU  -  Gao H
AU  -  Eng S
AU  -  Winslow C
AU  -  Ho T
AU  -  Turner KC
AU  -  Hassan HE
AU  -  Patel Y
AU  -  Davis JD
AU  -  Trinh N
AU  -  Manley A
AU  -  Manvelian G
AU  -  Fetell M
AU  -  Braunstein N
AU  -  Geba GP
AU  -  Dakin P.
PY  - 2024
JO  - Osteoarthr Cartil Open
DO  - 10.1016/j.ocarto.2024.100533
UR  - https://doi.org/10.1016/j.ocarto.2024.100533
ER  - 

APA

SJ, D., J, M., TJ, S., H, G., S, E., C, W., T, H., KC, T., HE, H., Y, P., JD, D., N, T., A, M., G, M., M, F., N, B., GP, G., & P., D. (2024). A phase III study to evaluate the long-term safety and efficacy of fasinumab in patients with pain due to osteoarthritis of the knee or hip.. Osteoarthr Cartil Open. https://doi.org/10.1016/j.ocarto.2024.100533

Source records